GB SCIENCES INC financial data

Location
Las Vegas, NV
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2024 - 12 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.8% % -62.05%
Debt-to-equity -101.7% % 3.3%
Return On Equity 18% % -77.1%
Return On Assets -762.9% % -184.93%
Operating Margin -872.53% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 407,071,028 shares
Common Stock, Shares, Outstanding 407,071,028 shares 0.25%
Common Stock, Value, Issued $40,821 USD 0.25%
Weighted Average Number of Shares Outstanding, Basic 407,071,028 shares 0.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $97,235 USD
Cost of Revenue $0 USD
General and Administrative Expense $163,826 USD -29.99%
Operating Income (Loss) $-848,407 USD 46%
Nonoperating Income (Expense) $-194,539 USD 91%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $-1,042,946 USD 72%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $-1,042,946 USD 72%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,016 USD -82.72%
Assets, Current $94,467 USD -35.79%
Assets $103,442 USD -70.64%
Accrued Liabilities, Current $145,500 USD 92%
Liabilities, Current $5,417,481 USD 10%
Liabilities $5,974,481 USD 20%
Retained Earnings (Accumulated Deficit) $-110,642,891 USD -0.95%
Stockholders' Equity Attributable to Parent $-5,880,014 USD -21.31%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $-5,880,014 USD -21.31%
Liabilities and Equity $94,467 USD -35.79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-21,991 USD 79%
Net Cash Provided by (Used in) Financing Activities $10,000 USD -60%
Common Stock, Shares Authorized 950,000,000 shares 0%
Common Stock, Shares, Issued 407,071,028 shares 0.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-11,991 USD 85%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $14,075,747 USD -2.97%
Deferred Tax Assets, Gross $14,075,747 USD -2.97%
Deferred Tax Assets, Operating Loss Carryforwards $11,058,990 USD 1.1%
Additional Paid in Capital $104,722,056 USD 0.01%
Amortization of Intangible Assets $0 USD -100%